1. Introduction
===============

Heterotrimeric guanine-nucleotide binding proteins (G-proteins) are best known for transducing a wide array of extracellular signals received from heptahelical (7TM) cell-surface receptors, such as those initiated by hormones in the bloodstream, neurotransmitters across the synapse, and photons striking the retina. In the conventional model of heterotrimeric G-protein activation, the ligand/7TM receptor interaction catalyzes guanine nucleotide exchange on the Gβγ-complexed (and GDP-bound) Gα subunit (Fig. [1](#F1){ref-type="fig"}). The Gα·GTP and Gβγ subunits of the heterotrimer then dissociate and are thus free to propagate the signal forward via separate (and sometimes converging) interactions with adenylyl cyclases, phospholipase‑C isoforms, potassium and calcium ion channels, guanine-nucleotide exchange factors for the GTPase RhoA ("RhoGEFs"), and other "effector" enzymes [@B1], [@B2], [@B3]. The intrinsic GTP hydrolysis (GTPase) activity of the Gα subunit resets the cycle by forming Gα·GDP which has low affinity for effectors but high affinity for Gβγ. Thus, the inactive GDP-bound heterotrimer (Gαβγ) is reformed, capable once again of interacting with activated receptor. Based on this cycle, the duration of heterotrimeric G-protein signaling is thought to be controlled by the lifetime of the Gα subunit in its GTP-bound state. In 1996, we and others identified a superfamily of RGS ("regulator of G-protein signaling") proteins that bind Gα subunits via a hallmark \~120 amino-acid "RGS-box" domain [@B4], [@B5], [@B6], [@B7], [@B8], [@B9], dramatically accelerating their intrinsic GTPase activity [@B10], [@B11], [@B12], and thus attenuating heterotrimer-linked signaling (reviewed in [@B13], [@B14], [@B15]). The discovery of the RGS proteins and their GTPase-accelerating (or "GAP") activity on Gα subunits not only resolved apparent timing paradoxes between known 7TM-receptor-mediated physiological responses and the activity*in vitro* of the responsible G-proteins (*e.g.*, [@B16]), but in addition, novel functional domains discovered within members of the RGS protein superfamily (Fig. [2](#F2){ref-type="fig"}) have helped to reveal hitherto unappreciated roles for Gα subunits in cellular processes outside the realm of 7TM receptor signaling.

2. The spectrum of RGS protein structure and function
=====================================================

Founding members of the RGS protein superfamily were discovered in 1996 in a wide spectrum of species: "supersensitivity to pheromone-2" (Sst2) in the budding yeast *Saccharomyces cerevisiae* [@B5], [@B19], [@B20], FlbA in the aspergillus *Emericella nidulans* [@B9], EGL-10 in the nematode worm *Caenorhabiditis elegans* [@B7], and RGS1 and RGS2 from human B- and T-lymphocytes, respectively [@B6], [@B8]. Nearly a decade later, new RGS-box-containing proteins are still being identified in mammalian species (*e.g.*, humans in Fig. [3](#F3){ref-type="fig"}) and even in plants (Fig. [4](#F4){ref-type="fig"}C). For example, RGS21 was recently identified as a putative component of taste bud signal transduction that is transacted in lingual epithelium via the T1R2/T1R3 sweet taste and T2R bitter taste 7TM receptors [@B21]. At a mere 152 amino-acids, RGS21 is the shortest RGS protein known to date, with no obvious structural domain N- or C-terminal to the central RGS-box. The singular nature of the RGS21 domain structure is typical of the A/RZ and B/R4 subfamilies (Figs. [2](#F2){ref-type="fig"}&[3](#F3){ref-type="fig"}) but is unlike other superfamily members that either contain two or more RGS-boxes in tandem (*i.e.*, the PKA regulatory subunit binding partner D‑AKAP2 [@B22] and the testes-specific protein PRTD-NY2 \[*a.k.a.* RGS22; Willard & Siderovski, unpublished observations\]) or possess one or more functional modules beyond the defining RGS-box (Fig. [2](#F2){ref-type="fig"}). Several recent findings as to the functions of these multi-domain RGS proteins are described below.

2.a. R7 RGS proteins as novel Gγ subunits
-----------------------------------------

In 1998, we identified a polypeptide sequence, N-terminal to the RGS-box within RGS6, RGS7, and RGS11, with similarity to conventional Gγ subunits [@B27]. This Gγ-like or "GGL" domain was subsequently shown by us [@B27], [@B37], [@B38] and others [@B39], [@B40], [@B41] to bind the neuro-specific outlier Gβ subunit: Gβ5. This constitutive GGL/Gβ5 interaction was also found to hold true for the *C. elegans* counterparts: the R7 subfamily RGS proteins EGL-10 and EAT-16 each form obligate dimers with the Gβ5-homolog, GPB-2 [@B42], [@B43]. This GGL/Gβ5 pairing presents the possibility that R7 RGS proteins not only serve as GAPs for activated Gα subunits, but also serve to couple inactive Gα subunits to 7TM receptors (Fig. [4](#F4){ref-type="fig"}A) akin to the function of conventional Gβγ subunits (Fig. [1](#F1){ref-type="fig"}) (reviewed in [@B44], [@B45]).

R7 RGS proteins also have an N-terminal DEP ([D]{.ul}ishevelled/[E]{.ul}GL-10/[P]{.ul}leckstrin homology) domain [@B46]. At least for the retinal-specific R7 RGS protein RGS9-1, a membrane-associated binding partner has been identified for the DEP domain: "[R]{.ul}GS[9]{.ul} [a]{.ul}nchor [p]{.ul}rotein" or R9AP [@B47], [@B48], [@B49], [@B50]. Proper functioning of RGS9-1 as a GAP for the Gα coupled to the retinal photoreceptor (rhodopsin), as well as proper membrane targetting of this GAP activity by R9AP, appear critical to normal vision; Dryja and colleagues have recently reported that loss-of-function mutations to RGS9-1 or R9AP are found in people with abnormalities in photoresponse recovery ("bradyopsia") that include an inability to see moving objects accurately, especially in low-contrast lighting, and difficulty adjusting to light intensity changes [@B51]. Although this is the first identified human mutation in an RGS protein causing pathological changes to the timing of 7TM signaling, we surmise that it will not be the last. Indeed, one could speculate that a component of essential hypertension might be due to loss-of-function mutation to RGS2; we and others have recently found that *Rgs2*-deficient mice [@B52] exhibit constitutive hypertension [@B53], [@B54], consistent with an earlier finding that RGS2 establishes an important negative feedback circuit on vasoconstrictive hormone signaling in vascular smooth muscle as mediated by 7TM receptors coupled to Gq heterotrimers [@B55].

2.b. Membrane targeting of other RGS proteins
---------------------------------------------

With the sheer number of RGS proteins identified (*e.g.*, at least 37 RGS proteins encoded by the human genome; Fig. [3](#F3){ref-type="fig"}), a central question has arisen as to how (and if) receptor selectivity is engendered for the GAP activity of specific RGS proteins. Similar to the relationship between RGS9‑1 and R9AP, other mechanisms of localizing RGS proteins to membranes and/or specific 7TM receptors are being uncovered. For example, we identified an N-terminal PDZ ([P]{.ul}SD-95/[D]{.ul}iscs-large/[Z]{.ul}O-1 homology) domain within the longest isoform of the R12 subfamily member RGS12 (Fig. [2](#F2){ref-type="fig"}); this PDZ domain is capable of binding peptides derived from the C‑termini of 7TM receptors, including from one of the interleukin-8 receptors (CXCR2) [@B56], [@B57]. With our colleague Dr. María Diversé-Pierluissi, we have also shown that, in dorsal root ganglion neurons, the phosphotyrosine-binding (PTB) domain of RGS12 mediates its recruitment to the α1B pore-forming subunit of the N‑type calcium channel (Ca~v~2.2) in a neurotransmitter- and phosphorylation-dependent manner (Fig. [4](#F4){ref-type="fig"}B) [@B29]. We have since mapped the RGS12 PTB docking site to the SNARE-binding or "synprint" region of the Ca~v~2.2 channel (Siderovski & Diversé-Pierluissi; manuscript submitted); the channel/PTB domain interaction, while phosphotyrosine-dependent, does not occur within a canonical Asn-Pro-X-(p)Tyr binding motif common to many PTB docking sites [@B58]. With the ability to interact with a multitude of proteins by virtue of its PDZ, PTB, and Ras-binding domains, along with Gα interactions via its RGS-box and GoLoco motif (described below), RGS12 in particular appears to be a signaling nexus or \'hub\' capable of coordinating signal transduction from receptor and/or non-receptor tyrosine-kinases and both monomeric (Ras-superfamily) and heterotrimeric G-protein subunits [@B13].

An important finding in the RGS field was made by Wilkie and colleagues when they observed receptor selectivity of RGS proteins [@B59]. As an example, RGS1 was observed to be a 1000-fold more potent inhibitor of carbachol- than cholecystokinin-stimulated Ca^2+^ mobilization in pancreatic acinar cells, despite both agonists having similar coupling profiles (*i.e.*, via Gq/11 family Gα subunits signaling to phospholipase C-β) [@B60]. Strikingly, the closely related RGS2, also a potent GAP for Gαq/11 family members [@B61] , was equipotent at inhibiting carbachol and cholecystokinin signaling. The molecular determinants of receptor-selective inhibition of G-protein signaling by RGS4 have been delimited to the N-terminal 58 amino acids of this protein [@B59]. Full-length RGS4 and RGS4(ΔN58) are equipotent GAPs*in vitro*, however RGS4 is a 10,000-fold more potent inhibitor of muscarinic signaling in the context of pancreatic acinar cells [@B59].

These early findings by Wilkie *et al.* helped initiate the concept that domains outside the RGS-box may have significant functional effects on signaling specificity and potency. Studies using ribozyme and RNA-interference (RNAi)-mediated knockdown of endogenous RGS proteins have reinforced this notion of complementary selectivity between GPCRs and RGS proteins. For example, in studies employing A-10 rat aortic smooth muscle cells, Neubig and colleagues found that ribozyme-mediated depletion of RGS3 selectively enhances carbachol signaling via the M3 muscarinic receptor, whereas analogous depletion of RGS5 only potentiates angiotensin II signaling via the AT1a receptor; RGS2-directed ribozyme treatment had no effect on either 7TM receptor signaling pathway [@B62]. An obvious molecular mechanism for engendering such receptor selectivity would be direct interaction between a 7TM receptor and an RGS protein. The multidomain architecture of RGS proteins (Fig. [2](#F2){ref-type="fig"}) provides several potential means by which this could occur. However, to date, there is only limited evidence that 7TM receptors directly interact with RGS proteins. As previously mentioned, we found the RGS12 PDZ domain can bind peptides corresponding to the C-terminal tail of the interleukin-8 (CXCR2) 7TM receptor *in vitro* [@B56], [@B57], but this interaction has not yet been tested with full-length proteins *in vivo*. A more recent report cites a finding of *in vitro* binding between an intracellular loop of the M1 muscarinic receptor and RGS2 as evidence for direct coupling between the M1 receptor and RGS2 GAP activity [@B63]. It would be more informative if loss-of-function mutants for the M1-RGS2 interaction (*i.e.*, mutations that do not disrupt G-protein activation or GAP activity) could be created and analyzed in a cell biological context. It must be emphasized that no report has yet demonstrated interaction between a full-length 7TM receptor and a full-length RGS protein in cells.

Our recent discovery of AtRGS1, the first plant RGS protein (from *Arabidopsis thaliana*), has given the clearest demonstration yet of functional linkage between an RGS-box and a particular 7TM receptor. Indeed, AtRGS1 is an amalgam of the two, with an N-terminal region predicted to have the topology and transmembrane domains of a 7TM receptor, along with a C-terminal intracytosolic RGS-box (Fig. [4](#F4){ref-type="fig"}C). Genetic evidence is consistent with a model that the action of the AtRGS1 RGS-box opposes that of the activated plant Gα (AtGPA1) in increasing cell elongation in hypocotyls in darkness and increasing cell production in roots grown in light [@B64]. In support of this model, we have shown AtRGS1 to be a potent GAP for AtGPA1 [@B64], [@B65]. The presence of both GEF-like (7TM) and GAP-like (RGS-box) domains within AtRGS1 may seem paradoxical; however, our prevailing hypothesis is that AtRGS1 represents a ligand-operated GAP, given that AtGPA1 exhibits a high rate of spontaneous nucleotide exchange, as well as slow intrinsic GTPase activity, in comparison to mammalian Gα subunits [@B65]. A definitive test of this "ligand-operated GAP" hypothesis awaits the identification of an agonist for the 7TM portion of AtRGS1. Although no ligand has yet been identified, a simple sugar appears the most likely candidate [@B66].

2.c. RGS-box-containing RhoGEFs as Gα effectors
-----------------------------------------------

Most RGS proteins are considered negative regulators of 7TM receptor signaling, either via Gα-directed GAP activity or by "effector antagonism" (*i.e.*, binding activated Gα·GTP in competition with effectors; *e.g.*, [@B67], [@B68], [@B69], [@B70]). In contrast, the three members of the F/GEF subfamily of RGS proteins (Figs. [2](#F2){ref-type="fig"}&[3](#F3){ref-type="fig"}), p115-RhoGEF, PDZ-RhoGEF, and leukemia-associated RhoGEF (LARG), represent *positive* regulators of 7TM receptor signaling -- specifically, as true effectors that couple Gαq, Gα12, and/or Gα13 subunits to activation of the GTPase RhoA. Thus, these RGS-box effectors link Gq-, G12-, and G13-coupled 7TM receptors to the panoply of cytoskeletal and transcriptional responses mediated by RhoA·GTP-dependent effectors [@B71], [@B72]. All three proteins possess an RGS-box N-terminal to DH (Dbl-homology) and PH (pleckstrin-homology) domains that, as a tandem, are responsible for catalyzing guanine nucleotide exchange necessary to convert inactive RhoA·GDP into active RhoA·GTP [@B73]. Kozasa*et al.* first demonstrated in 1998 that the RGS-box of p115-RhoGEF is a potent GAP for both Gα12 and Gα13 subunits [@B74]; more importantly, the same group found that interaction between the RGS-box and Gα13·GTP, but not Gα12·GTP, serves to trigger exchange activity by the C-terminal DH/PH cassette [@B75]. In contrast with p115-RhoGEF, LARG serves as a Gα-responsive RhoGEF not only for Gα13, but also for Gα12 and Gαq [@B76], [@B77]. The ability of LARG GEF activity to be stimulated by Gα12·GTP appears dependent on tyrosine phosphorylation of LARG ([@B78]), ostensibly by Tec-family kinases or focal adhesion kinase (FAK; [@B79]).

Recent work in PC-3 prostate cancer cells by Wang *et al.* suggests that these three RGS-RhoGEFs each couple distinct receptors to RhoA activation. RNAi-mediated knockdown of LARG specifically inhibited thrombin signaling via the 7TM protease activated receptor-1 (PAR1), whereas RNAi knockdown of PDZ-RhoGEF specifically inhibited lysophosphatidic acid receptor signaling; reduction of p115-RhoGEF levels had no effect on either response [@B80]. Of the three RhoGEFs, two of them possess an N-terminal PDZ domain: LARG and the eponymic PDZ-RhoGEF (Fig. [2](#F2){ref-type="fig"}). The mechanism whereby RGS-RhoGEF signaling specificity is engendered in PC‑3 cells remains unknown, but might entail direct 7TM receptor tail/PDZ domain interactions. It is known that LARG associates via its PDZ domain with the C-terminal tail of the insulin-like growth factor-1 (IGF-1) receptor, providing functional linkage between extracellular IGF-1 and RhoA-mediated cytoskeletal rearrangements [@B81], [@B82]. Both LARG and PDZ-RhoGEF also use their PDZ domains to bind plexin-B1 (Fig. [4](#F4){ref-type="fig"}D), a transmembrane receptor for the semaphorin Sema4D (*a.k.a.* "cluster of differentiation antigen 100" or CD100) [@B83]. Binding of Sema4D to plexin-B1 stimulates RhoA activation via LARG/PDZ-RhoGEF [@B84], [@B85], [@B86], [@B87], [@B88]. However, the role of the RGS-box in LARG/PDZ-RhoGEF signaling to RhoA activation via these latter, non-7TM receptors remains ill-defined.

3. Discovery of a new family of Gα regulators: The GoLoco motif proteins
========================================================================

A more recent addition to the pantheon of G-protein regulatory proteins is a diverse family of Gα-interacting proteins, all of which contain one or more conserved GoLoco ("Gα~i/o~-Loco" interaction) motifs (otherwise known as GPR or "G-protein regulatory" motifs) (Fig. [5](#F5){ref-type="fig"}A) [@B28], [@B90]. GoLoco motif-containing proteins generally bind to GDP-bound Gα subunits of the G~i~ (adenylyl-cyclase inhibitory) class and act as guanine nucleotide dissociation inhibitors (GDIs), slowing spontaneous exchange of GDP for GTP and inhibiting association with Gβγ subunits [@B91]. Our determination of the crystallographic structure of Gα~i1~·GDP in complex with the 36 amino-acid GoLoco motif of RGS14 [@B92] revealed critical determinants of Gα subunit specificity and GDI activity. The N-terminal alpha-helix of the GoLoco peptide was seen sandwiched between switch II and the α3 helix of the Gα~i1~ Ras-like lobe (Fig. [5](#F5){ref-type="fig"}B), grossly deforming the normal site of Gβγ interaction [@B92]. The highly conserved aspartate-glutamine-arginine triad, which defines the final residues of the highly-conserved 19 amino-acid GoLoco signature (Fig. [5](#F5){ref-type="fig"}A), was found to orient the arginine residue into the guanine nucleotide binding pocket of Gα, allowing contacts to be made between its basic δ-guanido group and the α- and β-phosphates of GDP (Fig. [5](#F5){ref-type="fig"}B). Loss of GDI activity results from mutation of this arginine [@B92], [@B93], or of the preceding aspartate which aids its orientation [@B94].

The family of known GoLoco motif-containing proteins represents a diverse set of signaling regulators, each first discovered and characterized in vastly different contexts; accordingly, their nomenclature is often misleading or uninformative. Here we describe these proteins using their newly-approved Human Genome Organisation (HUGO) nomenclature (http://www.gene.ucl.ac.uk/nomenclature/). One subset of GoLoco proteins includes the R12 subfamily of RGS proteins: RGS12, RGS14, and the *Drosophila* ortholog Loco. We originally cloned both RGS12 and RGS14 in 1997 from rat C6 glioblastoma cells using degenerate PCR primers directed to sequences conserved within all RGS-box domains [@B57], [@B95]. In addition to a hallmark RGS-box and tandemly-repeated Ras-binding domains, each of these R12-subfamily members contains a single, C-terminal GoLoco motif that is a GDI for Gα~i~ subunits [@B96], [@B97]. Concomitant with our discovery of RGS12 and RGS14, the latter protein was also isolated as a putative effector for Rap2·GTP in a yeast two hybrid screen for Rap2-interacting proteins [@B98]. A second subset of GoLoco proteins, consisting of the [G]{.ul}-[p]{.ul}rotein [s]{.ul}ignaling [m]{.ul}odulator protein GPSM1 (formerly AGS3 [@B90]), GPSM2 (formerly LGN [@B99]), and the *Drosophila* ortholog Partner of Inscuteable (Pins/Rapsynoid; [@B100], [@B101]), all contain a tandem array of three to four GoLoco motifs at their C-terminus, along with an N-terminal region of multiple tetratricopeptide repeats (TPRs; Fig. [5](#F5){ref-type="fig"}A). The *Caenorhabditis elegans* proteins GPR-1 and GPR-2 are distantly related (Fig. [6](#F6){ref-type="fig"}) to GPSM1, GPSM2, and Pins, and have only one easily-identifiable GoLoco motif [@B102], [@B103], [@B104]. A third subfamily consists of GPSM3 (formerly G18 [@B94]), and Purkinje cell protein-2 (Pcp-2, *a.k.a.* GPSM4 [@B105]); both are small proteins that contain between one and three GoLoco motifs (depending on alternative splicing), but no other identifiable functional domains. The sole member of the fourth and final subset of GoLoco proteins is Rap1GAP. With a few limited exceptions, all the aforementioned GoLoco-containing proteins demonstrate GDP-dependent interaction with Gα~i/o~ subunits and function as GDIs for Gα subunits.

Currently, the only compelling evidence that a GoLoco motif-containing protein acts within the framework of canonical GPCR signaling (outside the R12-subfamily RGS proteins; Fig. [4](#F4){ref-type="fig"}) has been provided by studies of Rap1GAP as a potential effector for Gα~i/o/z~ subunits. The Rap1GAPII isoform, originally described by Mochizuki and colleagues [@B106], contains a 31 amino-acid N-terminal extension encoding a full GoLoco motif. *In vivo* characterization of Rap1GAPII suggested that the GoLoco-containing region specifically interacts with constitutively-activated, GTPase-deficient Gα~i~(Q205L) [@B106]. In contrast,*in vitro* studies indicated a strong preference for interaction with GDP-bound Gα~i~ and, consequently, a biochemical function as a GDI [@B107]. Activation of G~i~-coupled 7TM receptors can recruit Rap1GAPII to the plasma membrane to accelerate GTP hydrolysis by Rap1. Deactivation of Rap relieves an inhibitory constraint on Ras, thus promoting activation of the MAPK pathway [@B106]. Similarly, Gα~z~-coupled 7TM receptors also employ Rap1GAPI to attenuate Rap1-mediated ERK activation and PC12 cell differentiation [@B108], [@B109]. However, some discrepancies exist between these reports describing GTP-dependent Gα/Rap1GAP interactions and a report showing that Gα~o~-GDP interacts with Rap1GAP to block Rap-directed GAP activity [@B110]. It may be that Gα/Rap1GAP interactions are contextually determined by cell-type and splice-form, and also that multiple Gα-binding sites might exist on Rap1GAP isoforms. Nonetheless, these studies indicate that, at least in the cell transfection paradigm, the GoLoco protein Rap1GAP can modulate 7TM receptor signaling; however, the field requires future studies to further delineate the mechanisms of GoLoco-mediated regulation of 7TM receptor signal transduction.

In sharp contrast to the studies on Rap1GAP, there is a paucity of evidence supporting GoLoco motif-mediated modulation of 7TM receptor signaling in physiologically-relevant systems. Results from our lab and from others indicate that GPSM1-4 proteins do not appear to modulate conventional aspects of 7TM receptor signal transduction. That is, gross overexpression of GPSM1-4 proteins does not alter either the kinetics or magnitude of receptor-induced effector activation. We interpret this to indicate that many GoLoco motif proteins may be spatially segregated from interacting with plasma membrane-delimited 7TM receptor signaling components. Indeed, Graber and colleagues demonstrated this using Sf9 insect-cell membranes overexpressing GPSM1 and the 5-HT~1A~ serotonin receptor [@B111]. Membrane-bound GPSM1 did not affect receptor coupling, but adding soluble GPSM1 protein to the membrane preparation attenuated high affinity agonist binding. A recent report indicates that overexpression of GPSM1 in COS-7 cells may have a modest effect on adenylyl cyclase sensitization and Gα~i3~ subunit stability [@B112]; however, the physiological relevance of this phenomenon remains to be elucidated. In this light, a recent report indicates that GPSM1 is upregulated in the rat prefrontal cortex following withdrawal from repeated cocaine administration [@B113]. Evidence suggests that GPSM1 modulates cocaine-induced plasticity in 7TM receptor signaling, as increased GPSM1 expression correlates with attenuated G~i~-coupled receptor signal transduction [@B113]. Thus, rather than having a role as acute elements of G-protein signal modulation, the GPSM proteins may function as Gα \'sinks\' to regulate the overall availability and stability of the Gα component of the heterotrimeric G-protein cycle.

With a view to placing GoLoco motif-containing proteins within the classical paradigm of 7TM receptor signal transduction, it has been suggested that GoLoco motifs may activate heterotrimeric G-protein signaling by actively displacing Gβγ from Gα [@B90], [@B100], [@B114]. Indeed, Smrcka and colleagues have demonstrated that a GoLoco consensus peptide can actively displace Gβγ from a preformed heterotrimer, although at a rather high 20,000-fold molar excess *in vitro* (*i.e.*, 1 μM GPSM1 consensus peptide mixed with 50 pM Gαβγ) [@B115]. However, using similar levels of GoLoco peptides (10 μM) microinjected into cells, it appears that GoLoco proteins only have access to Gα·GDP following a cycle of receptor-mediated GEF activity. In a recent study, Oxford and colleagues measured G~i~-coupled activation of Kir~3.1/3.2~ potassium channels (a Gβγ-mediated process; Fig. [7](#F7){ref-type="fig"}A) to interrogate the ability of GoLoco peptides to promote Gβγ signaling [@B116]. Electrophysiological recordings of potassium channel currents activated via D2-dopamine receptor stimulation were made in AtT-20 cells. Intracellular application of GoLoco peptides derived from RGS12 and GPSM1 had little effect on single agonist application-induced channel activation (*e.g.*, sample data in Fig. [7](#F7){ref-type="fig"}B; C.K. Webb, C.R. McCudden, F.S. Willard, R.J. Kimple, D.P. Siderovski, G.S. Oxford; manuscript submitted). However, repeated applications of the D2-receptor agonist quinpirole produced progressive uncoupling of receptor and effector (*e.g.*, Fig. [7](#F7){ref-type="fig"}B). Repeated activation of potassium current in the same cells using somatostatin, a G~o~-coupled 7TM receptor-mediated response, was unaffected by GoLoco peptide application, consistent with the Gα~i~-selective nature of the GoLoco peptides employed. These results indicate that, if GoLoco motifs do have a functional role in modulating 7TM receptor signaling, it may be more subtle to discern than has previously been appreciated.

4. GoLoco motif proteins and a novel Gα nucleotide cycle involved in cell division
==================================================================================

Although the GoLoco motif was first discovered in the context of 7TM receptor signaling, a central role is emerging for GoLoco motif-containing proteins in an unexpected arena: the control of mitotic spindle organization, microtubule (MT) dynamics, and the act of chromosomal segregation during cell division. Early evidence supporting a connection between Gα subunits, GoLoco proteins, and MT dynamics has arisen from studies of asymmetric cell division (ACD) in model organisms.

4.a. Gα and GoLoco protein involvement in *Drosophila* asymmetric cell division
-------------------------------------------------------------------------------

One of the first observations that placed a GoLoco protein within the machinery of cell division was the finding that a complex between Gα and the multi-GoLoco protein Partner of Inscuteable (Fig. [8](#F8){ref-type="fig"}) is crucial for dictating ACD in *Drosophila* neuroblasts [@B100], [@B101]. Upon delamination from ventral neuroectoderm, these neuroblast cells adopt an apical-basal axis of polarity and divide asymmetrically along this axis to produce a large apical neuroblast competent for further ACD and a small ganglion mother cell committed to differentiation (reviewed in [@B117]). In this process, apical determinants Bazooka (PAR3), PAR6, and atypical protein kinase C (aPKC) form a protein complex that recruits the *Drosophila* protein Inscuteable (dInsc) to the apical cortex [@B118], [@B119]. Loss of *inscuteable* expression leads to mislocalization of basal determinants Numb and Prospero, as well as misorientation of the mitotic spindle and, thus, randomization of the plane of cell division with respect to the apical-basal axis [@B120].

Deletional analysis of dInsc has defined a central Armadillo repeat-containing "asymmetry domain" sufficient to mediate all known functions of the full-length protein [@B121], [@B122]. In searching for asymmetry domain-interacting proteins as potential dInsc effectors, three groups independently discovered the GoLoco motif-containing Partner of Inscuteable (Pins) protein [@B100], [@B101], [@B123]. Pins is the archetypal member of a conserved class of TPR and GoLoco-motif containing proteins involved in cell division processes (GPSM1, GPSM2, Pins; Fig. [5](#F5){ref-type="fig"}A). dInsc, Pins, and *Drosophila* Gαi form an apical protein complex essential for neuroblast ACD; ablation of maternal and zygotic Pins results in defective spindle orientation, a failure to segregate determinants asymmetrically, and a limited asymmetry in neuroblast division [@B100], [@B101], [@B123]. Similarly, overexpression of wildtype Gαi inhibits polarization of asymmetry determinants and causes mitotic spindle misorientation [@B124]. However, overexpression of constitutively-active (*i.e.*, GTPase-deficient) Gαi(Q205L) has essentially no effect on neuroblast ACD. Thus, in the specific example of *Drosophila* neuroblast ACD, the functional Gα species appears not to be GTP-bound Gαi (the active form in 7TM receptor signaling; Fig. [1](#F1){ref-type="fig"}), but rather Gαi·GDP in complex with the GoLoco protein Pins. It is possible that Gβγ sequestration by elevated levels of Gαi·GDP leads to the observed aberrations in neuroblast ACD. However, significant differences are seen in daughter cell size and cell-fate determinant mislocalization upon Gαi overexpression versus loss of Gβ13F (ortholog of the mammalian Gβ subunits Gβ1-4) [@B124], [@B125]. It is also important to note that the Insc/Pins/Gαi·GDP complex isolated from *Drosophila* neuroblasts is devoid of Gβ13F [@B124], consistent with the mutually-exclusive nature of GoLoco- *vs* Gβγ-binding to Gα·GDP.

4.b. Involvement of Gα and GoLoco proteins GPR-1/-2 in *C. elegans* asymmetric cell division
--------------------------------------------------------------------------------------------

The involvement in ACD of many of these polarity proteins is conserved throughout metazoan organisms [@B91], [@B126]. Early evidence that Gα subunits also function in ACD in the nematode worm*C. elegans* came from studies in which simultaneous RNA interference (RNAi)-mediated knockdown of two *C. elegans* Gα subunits, GOA-1 (a Gα~o~ homolog) and GPA-16 (a Gα~i~ homolog), was found to cause a mitotic spindle positioning defect resulting in symmetric division of the nematode zygote [@B127]. Normally, division of the one-cell stage (P~0~)*C. elegans* embryo is asymmetric, yielding a large anterior (AB) blastomere and a smaller posterior blastomere (P~1~). The mitotic spindle at metaphase of this first division is symmetrically positioned along the anterior-posterier axis, but during anaphase the anterior centrosome remains fixed while the posterior centrosome moves toward the posterior cortex with a characteristic rocking motion. These events are believed to originate from asymmetric forces acting through astral MTs that radiate from the mitotic spindle poles to the cell cortex.

Grill *et al.* recently employed UV laser-induced centrosome disintegration on one-cell*C. elegans* embryos to study the basis of this net force imbalance [@B128]; calculations based on observed speeds of centrosome fragmentation led Grill *et al.* to conclude that the force imbalance results from a larger number (\~50% more) of force generators in the posterior cortex pulling on astral MTs (relative to the anterior cortex), rather than an increase in the magnitude of force derived from each force generator. In these studies, RNAi-mediated knockdown of GOA‑1 and GPA‑16 was found to greatly reduce aster fragmentation speeds upon laser-induced centrosome disintegration [@B128], suggesting that some form of Gα signaling during *C. elegans* ACD is required to mediate posterior astral MT force generation.

A functional genomic screen for genes regulating early *C. elegans* embryo cell division by Gönczy and colleagues identified the Pins-related GoLoco proteins GPR-1 and GPR-2 (Fig. [5](#F5){ref-type="fig"}A & [9](#F9){ref-type="fig"}) [@B129]. GPR-1 and -2 are essential for establishing proper pulling forces during asymmetric P~0~ division in *C. elegans*[@B102]. RNAi-mediated reduction in expression levels of these two, near-identical GoLoco proteins leads to a spindle positioning defect indistinguishable from that seen in *goa-1*/*gpa-16* (*RNAi*) embryos [@B102], [@B127]. In laser-mediated spindle-severing studies, Colombo *et al.* established that, during normal asymmetric division, the peak velocity of the posterior spindle pole is \~40% greater than that of the anterior one, presumably reflecting a larger net pulling force by astral MTs [@B102]. In contrast, anterior and posterior spindle pole velocities are both equal and greatly reduced in *gpr-1*/*-2* (*RNAi*) embryos and in *goa-1*/*gpa-16* (*RNAi*) embryos [@B102]. Immunofluorescence studies revealed \~50% more GPR-1/-2 protein on the posterior cortex; this asymmetric cortical distribution of GPR‑1/‑2 is dependent on PAR-3 function [@B102], and nicely correlates with Grill\'s calculation of \~50% more force generators at the posterior cortex [@B128] (described above), suggesting that GPR-1/-2 may specify motor localization and/or directly transact a function required for force generation on astral microtubules during chromosomal segregation. These findings by Colombo *et al.* that the GoLoco proteins GPR-1 and GPR-2 are critical to *C. elegans* ACD are wholly consistent with independent reports published simultaneously [@B103], [@B104].

4.c. Gα-directed GEF and GAP activities implicated in *C. elegans*asymmetric cell division
------------------------------------------------------------------------------------------

Not only are Gα subunits (GOA-1, GPA-16) and GoLoco proteins (GPR-1, GPR-2) required for asymmetric P~0~ division in *C. elegans*, but other novel regulators of the Gα guanine nucleotide cycle have also emerged from genetic studies as being critical to this process. For example, Miller [@B131], [@B132] first isolated a novel gene *ric-8* ("resistance to inhibitors of cholinesterase", *a.k.a.* Synembryn) as an upstream regulator of the *C. elegans* Gα~q~-like protein EGL-30. *ric-8* reduction-of-function mutants (*md303, md1909*) were found to have high rates of embryonic lethality, which could be augmented to almost 100% in embryos heterozyous for *goa-1* loss-of-function alleles, thus suggesting that RIC-8 and GOA-1 proteins signal in the same pathway during embryogenesis [@B133]. Reduced posterior centrosome rocking during the P~0~ cleavage was observed in *ric-8* mutant embryos, as well as loss of mitotic spindle and daughter blastomere asymmetries. Most compelling is that these *ric-8* mutant phenotypes are reminiscent of those seen in *goa‑1*/*gpa‑16* (*RNAi*) embryos.

It is believed that RIC-8 may represent a novel, receptor-independent guanine nucleotide exchange factor (GEF) for Gα subunits. Tall *et al.* recently isolated the rat paralogues Ric-8A and Ric-8B in a yeast two-hybrid screen for Gα~s~- and Gα~o~-interacting proteins [@B134]; their initial biochemical analyses indicated that rat Ric‑8A can act as a GEF *in vitro* for several mammalian Gα subunits, including Gα~i1~, Gα~o~ and Gα~q~. The GEF activity of rat Ric-8A was found to have characteristics distinct from those of 7TM receptors; specifically, Ric-8A appears to interact preferentially with isolated Gα·GDP subunits to accelerate the release of GDP by Gα, the rate limiting step in the G-protein cycle [@B135]. It is important to stress that, in this initial study, Ric-8A was found to be *unable* to catalyze the loading of GTP onto "heterotrimeric" Gα (Gα·GDP bound to Gβγ) [@B134]. Irrespective of this initial finding with rat Ric-8A, there are no published reports that the *C. elegans* RIC-8 protein can act as a GEF for the nematode Gα subunits GOA-1 or GPA-16. More importantly, it has not been determined whether mammalian Ric-8A or *C. elegans*RIC-8 can act as a GEF for GoLoco-bound Gα·GDP subunits. The Ric-8 gene is highly evolutionarily conserved, but the encoded protein has no obvious domain or motif structure. We have observed Ric-8 orthologues in the *Drosophila*, mouse, and human genomes (GenBank NP_572550, NP_444424, and NP_068751, respectively). It is tempting to speculate that deletion of (or loss-of-function mutations in) *Drosophila* Ric-8 will lead to severe phenotypes affecting neuroblast ACD. Similarly, it will be important to examine the physiological roles of Ric-8A and Ric-8B in mammals. The field of mammalian asymmetric cell division is underdeveloped in comparison to *C. elegans* and *Drosophila*. Nonetheless there are increasingly powerful approaches being used to study this process in the developing mouse zygote [@B136] and nervous system [@B137] that should be employed to investigate the roles of these novel Gα regulators in ACD.

Timely deactivation of Gα·GTP may also be required for proper P~0~ division in *C. elegans*. Koelle and Hess have discovered that*rgs-7*, one of the 13 *C. elegans* RGS genes (*rgs-1* to *-11*, *eat-16*, *egl-10*), is intimately involved in asymmetric P~0~ division. Loss of *rgs-7*, encoding a potential GAP for both GOA‑1·GTP and GPA‑16·GTP, results in overly vigorous posterior centrosome rocking (H. Hess & M. Koelle, personal comm.; reviewed in [@B91]). Their finding implies that elevated Gα·GTP levels, presumably by loss of RGS-7 GAP activity, may result in excess force by astral MTs and further implies that, at least in the nematode, Gα·GTP may be the active species for force generation. These genetic and RNAi-based studies have identified Gα subunits and three novel Gα regulatory activities (GDI, GEF, and GAP proteins) as having critical roles in the process of *C. elegans* ACD, as summarized in Fig. [10](#F10){ref-type="fig"}A. Thus, initial findings from both *Drosophila* and *C. elegans* genetics suggest that Gα subunits and novel regulators of their guanine nucleotide cycle play critical and evolutionarily-conserved roles in establishing appropriate astral MT force on the mitotic spindle for proper chromosomal segregation. Collectively, this initial evidence suggests a preliminary working model in which productive cycling of Gα~i~ subunits between GDP- and GTP-bound states, established through the actions of GoLoco GDI, Ric-8 GEF, and RGS-box GAP activities, is required for mitotic spindle organization and function.

4.d. A novel Gα nucleotide cycle?
---------------------------------

In establishing an initial model of Gα nucleotide cycling underlying ACD that explains the genetic evidence (Fig. [10](#F10){ref-type="fig"}B; [@B91], [@B103]), several assumptions and accommodations have been made that demand verification by biochemical studies. For example, the biochemical actions on isolated Gα subunits currently assumed for GoLoco proteins and for RIC-8 are actually diametrically opposed: GDI activity preventing nucleotide release *vs* GEF activity promoting nucleotide release, respectively. Yet these opposing biochemical activities, when individually removed by RNAi or loss-of-function mutation, result in the *same* nematode zygote phenotype of decreased force and symmetric division (Fig. [10](#F10){ref-type="fig"}A). To accommodate this apparent enigma, we and others propose that RIC-8 requires interdiction by the GPR-1/-2 GoLoco motif to function on GOA-1 and/or GPA-16 (Fig. [10](#F10){ref-type="fig"}B). Indeed, this would be consistent with the findings of Tall *et al.* [@B134] that rat Ric-8A cannot operate on Gβγ-complexed Gα subunits. Our initial hypothesis, therefore, is that Gβγ is somehow excluded from or removed from GOA‑1/GPA‑16 subunits by the GPR-1/-2 GoLoco motif and, perhaps, GPR‑1/‑2 proteins "present" Gβγ-free Gα·GDP to RIC-8, thus acting cooperatively with RIC-8 to facilitate nucleotide exchange (Fig. [10](#F10){ref-type="fig"}B). A complication of this theory is that, although GoLoco-derived peptides might be able to disrupt a heterotrimer *in vitro* [@B115], [@B124], this "heterotrimer-splitting" activity appears unlikely to happen under physiological conditions (*e.g.*, Fig. [7](#F7){ref-type="fig"}) [@B116]. An alternative explanation suggested by the ion channel data of Oxford and Webb is that an initial round of GEF activity is required on the heterotrimer to remove Gα·GTP from the proximity of Gβγ, and then GTP hydrolysis produces Gα·GDP now competent to interact with the GoLoco motif of GPR-1/2 rather than re-associate with Gβγ. RIC-8 cannot provide this initial round of GEF activity if it cannot act on the Gαβγ heterotrimer [@B134]; thus, either 7TM receptor-mediated GEF activity, another (unknown) GEF activity, or a non-GEF "Gβγ releasing factor" would have to operate on the heterotrimer to establish this pathway.

Another possibility to consider is that the crucial parameter determining the output of the system (*i.e.*, astral MT force generation) is the overall rate of the Gα nucleotide cycle, as accelerated by the combined actions of RIC-8 and RGS-7 (Fig. [11](#F11){ref-type="fig"}). A key observation in this vein is provided by studies from Neubig and colleagues on the effect of RGS proteins on the receptor-catalyzed G-protein cycle. Using reconstituted components, it was observed that, in addition to facilitating steady-state GTP hydrolysis, RGS-box proteins also potently increased receptor-stimulated GTPγS binding [@B138]. This was not due to a physical scaffolding mechanism, rather a kinetic scaffolding or \'spatial focusing\' phenomenon [@B138]. This has previously been observed in the context of potassium channel regulation in which RGS proteins accelerate the kinetics of *both* channel activation and deactivation without altering the steady-state level of channel conductance [@B139], [@B140]. Thus in asymmetric cell division, it may be that rapid Gα GTPase cycling promoted by RIC-8 and RGS-7 provides a high-efficiency, spatially-localized signaling complex, sufficient for force generation.

4.e. Direct tubulin/Gα interaction as a model for the mechanism of MT force generation?
---------------------------------------------------------------------------------------

Forward genetic studies in *Drosophila* and, especially, *C. elegans* (Fig. [10](#F10){ref-type="fig"}A) have pointed to a critical role in metazoans for Gi-family Gα subunits and their regulators in controlling force generation on astral MTs during chromosomal segregation. One simple model to potentially explain this genetic evidence is that Gα~i~ subunits interact directly with MTs at their stable tubulin·GTP caps to enhance cap stability and MT elongation [@B143], [@B144], and that this tubulin/Gα~i~ interaction is dependent on the nucleotide state of Gα. Previous findings from Rasenick and colleagues indicate that mammalian Gα subunits directly interact with tubulin and MTs and modulate their dynamics *in vitro*. High-affinity binding (K~D~ ≈ 120 nM; ref. [@B145]) between Gα~i1~ and tubulin·GTP has been shown to result in Gα~i1~ "transactivation" (*i.e.*, GTP transfer to Gα from the exchangable binding-site on β‑tubulin [@B146], [@B147], [@B148], [@B149]). Moreover, in the absence of GTP or presence of non-hydrolyzable GppNHp, Gα~i1~ serves as a GAP for tubulin·GTP *in vitro* [@B150], activating its GTPase activity and increasing the frequency of MT "catastrophe" (the transition from slow growth to rapid shortening [@B151]); these effects of Gα~i1~ are inhibited in the presence of GTP and, indeed, MT assembly by tubulin is *enhanced* by Gα~i1~ in high GTP levels [@B150]. Goldstein and colleagues have recently developed a live cell imaging technique, "cortical imaging of microtubule stability" (CIMS), to visualize microtubule dynamics in real-time in the *C. elegans* zygote [@B152]. Using CIMS, it was demonstrated that anterior MTs reside longer at the cell cortex than do posterior MTs. However, in *goa‑1/gpa‑16 (RNAi)* zygotes, anterior and posterior microtubules have equal stability at the cell cortex. This provides direct evidence that Gα subunits regulate microtubule dynamics *in vivo* and is consistent with a Gα·GDP/GPR-1/-2 complex regulating cortical force generation. However, it remains to be directly tested whether direct interactions between tubulin and Gα mediate force generation, or whether members of the kinesin and dynein motor protein superfamilies [@B153], [@B154] and/or other microtubule-associated proteins at MT ends are the ultimate force generators, with their actions directly modulated by Gα subunits. Future studies in this field should be aimed at delineating the molecular mechanisms by which the novel Gα nucleotide cycle, composed of novel GDI, GEF, and GAP activities, communicates with microtubule machinery.

5. Conclusions
==============

Since the discovery of the RGS proteins and their Gα-directed GAP activity in 1996, there has been a considerable shift in our collective appreciation of RGS protein function in 7TM receptor signal transduction. Far from being mere negative regulators, RGS proteins also serve roles as Gα effectors (*e.g.*, the RGS-RhoGEFs), signaling scaffolds (*e.g.*, RGS12), and (potentially) as novel Gβγ-like dimers coupling Gα to receptors (*e.g.*, the R7/Gβ5 dimers). Moreover, the discovery of the GoLoco motif, first found in RGS12 and RGS14, has illuminated a novel GDI activity for Gα subunits involved in an equally novel interplay between Gα and tubulin controling microtubule force generation critical to chromosomal segregation during cell division. Further exploration of the structural features of RGS protein superfamily members and their functional effects on signal transduction complexes should provide additional surprises.
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![**Standard model of the guanine nucleotide cycle governing 7TM receptor-mediated activation of heterotrimeric G protein-coupled signaling.** The Gβγ heterodimer serves to couple Gα to the receptor and also to inhibit its spontaneous release of GDP (*i.e.*, acting as a guanine nucleotide dissociation inhibitor or "GDI" for Gα [@B17], [@B18]). Ligand-occupied, 7TM cell-surface receptors stimulate signal onset by acting as guanine nucleotide exchange factors (GEFs) for Gα subunits, facilitating GDP release, subsequent binding of GTP, and release of the Gβγ dimer. Both the GTP-bound Gα and liberated Gβγ moieties are then able to modulate the activity of various enzymes, ion channels, and other effectors. Regulator of G-protein signaling (RGS) proteins stimulate signal termination by acting as GTPase-accelerating proteins (GAPs) for Gα, dramatically enhancing their intrinsic rate of GTP hydrolysis.](ijbsv01p0051g01){#F1}

![**Multidomain architecture of representative members from all subfamilies of the mammalian RGS protein superfamily.** Two alternative nomenclatures have been proposed for several RGS protein subfamilies [@B23], [@B24]. RZ- or **A**-subfamily members such as RGS17 [@B25] are characterized by an N-terminal poly-cysteine region ("Cys") thought to be reversibly palmitoylated [@B26]. R4- or **B**-subfamily members include RGS2 and RGS21 that are described in the text. RGS11 was the first member of the R7- or **C**-subfamily to be shown to bind Gβ5 via its Gγ-like or "GGL" domain [@B27]. Of the three members of the R12- or **D**-subfamily (RGS10, RGS12, RGS14), RGS10 is the smallest and comprises little more than an RGS-box [@B11], whereas both RGS12 and RGS14 have tandem Ras-binding domains (RBDs) and a C-terminal Gαi/o-Loco interaction (GoLoco) motif [@B28], and RGS12 additionally has N-terminal PDZ (PSD95/Dlg/ZO-1 homology) and PTB (phosphotyrosine-binding) domains [@B29]. Axin and Axin2 (*a.k.a.* Axil) are negative regulators of the Wnt signaling pathway and comprise the RA- or **E**-subfamily; neither protein has been shown to interact with Gα subunits, but rather interact with the tumor suppressor protein adenomatous polyposis coli (APC) using the RGS-box [@B30]. Axin and Axil also contain other domains that interact with β-catenin, the kinase GSK3β, the phosphatase PP2A, and the protein Dishevelled ("DIX" domain) [@B31]. The GEF- or **F**-subfamily includes three RhoA-specific guanine nucleotide exchange factors ("GEFs") with canonical Dbl-homology (DH) and pleckstrin-homology (PH) domains: p115-RhoGEF, PDZ-RhoGEF, and leukemia-associated RhoGEF (LARG); the latter two RhoGEFs each possess an N-terminal PDZ domain, as described in the text. In 1996, we were the first group to identify [@B8] an N-terminal RGS-box within each member of the G protein-coupled receptor kinase family (known as the GRK- or **G**-subfamily in the context of the RGS protein superfamily). At least three sorting nexins (SNX13, SNX14, SNX25) have RGS-boxes between phosphatidylinositol-binding (PX) and PX-associated (PXA) domains and thus comprise the SNX- or **H**-subfamily of RGS proteins. Zheng and colleagues reported that SNX13 (*a.k.a.* "RGS-PX1") could act as a GAP for the adenylyl-cyclase-stimulatory isoform of Gα (Gα~s~) [@B32]; however, this report has yet to be confirmed in the literature. TM, putative transmembrane regions. The multiple RGS-box family members D-AKAP2 and RGS22 fall outside the eight established subfamilies; the superscript designations of their RGS-boxes match that used in Figure [3](#F3){ref-type="fig"}.](ijbsv01p0051g02){#F2}

![**Relationship between RGS-box sequences of all 37 human RGS proteins identified to date.** Unrooted dendrogram was generated by Clustal-W [@B33] and TreeView [@B34] using sequences identified by the SMART profile [@B35] for RGS-boxes as well as those identified by protein-fold recognition algorithms [@B36]. Subfamily designations and identification of isolated RGS-box sequences from multi-RGS-containing proteins D-AKAP2 and RGS22 are as described for Figure [2](#F2){ref-type="fig"}. Note that there is no RGS15, contrary to an early report [@B7].](ijbsv01p0051g03){#F3}

![**Membrane targeting strategies employed by multi-domain RGS proteins.** (**A**) The R7 RGS proteins form obligate heterodimers with Gβ5 via a Gγ-like sequence (the "GGL" domain) N-terminal to the RGS-box [@B37]. This GGL/Gβ5 interaction could allow R7 RGS proteins to act as conventional Gβγ subunits in coupling Gα subunits to 7TM receptors, thereby localizing RGS-box-mediated GAP activity to particular receptors [@B44]. The DEP domain of RGS9-1 interacts with a membrane-anchoring protein (R9AP) [@B47]; analogous interactors may exist for the DEP domains of other R7 subfamily members [@B89]. (**B**) The PDZ domain of RGS12 is able to bind the C-terminus of the IL-8 receptor CXCR2 (at least *in vitro*) [@B57]. The RGS12 PTB domain binds the synprint ("[syn]{.ul}aptic [pr]{.ul}otein [int]{.ul}eraction") region of the N-type calcium channel (Ca~v~2.2); this interaction is dependent on neurotransmitter-mediated phosphorylation of the channel by Src [@B29]. (**C**) The AtRGS1 protein of *Arabidopsis thaliana* (thale cress) has a unique structure for an RGS protein: an N-terminus resembling a 7TM receptor and a C-terminal RGS-box [@B64]. Although a ligand is not known for the 7TM portion of AtRGS1, a simple sugar is most likely [@B66]. (**D**) The transmembrane receptor Plexin-B1 couples binding of the membrane-bound semaphorin Sema4D to RhoA activation via an interaction with the PDZ domain of PDZ-RhoGEF (and of the related RGS-RhoGEF LARG) [@B88]. Domain abbreviations [@B35]: IPT, immunoglobulin-like fold found in plexins, Met and Ron tyrosine kinase receptors, and intracellular transcription factors; PSI, domain found in plexins, semaphorins, and integrins; Sema, semaphorin domain.](ijbsv01p0051g04){#F4}

![**The GoLoco motif, a Gα~i/o~-interacting polypeptide found singly or in arrays in various proteins, binds across the face of Gα.** (A) Alignment of the highly-conserved, 19 amino-acid GoLoco motif signatures from human RGS12 and RGS14 is colored according to side-chain chemistry using Clustal-X defaults [@B33]. Consensus symbols for amino-acid character are hyphen (-), acidic; Φ, hydrophobic; Ψ, large aliphatic; (+), basic; and π, small side chain. Domain abbreviations: RapGAP, Rap-specific GTPase-activating protein domain. (B) Our structure of Gα~i1~ (*green* with translucent space-filling shell; switch regions in *blue*) bound to a 36-amino acid peptide derived from the GoLoco motif-region of RGS14 [@B92]. The GoLoco peptide (*yellow*) binds across both Ras-like and all α-helical lobes within Gα~i1~, trapping GDP (*brown*) within its binding site. Note the relative position of the GoLoco triad\'s arginine "finger" (*yellow* in ball-and-stick representation) reaching into the GDP binding site. Gα~i1~-specific contacts from the α-helical lobe to the C-terminal portion of the GoLoco peptide are denoted in magenta.](ijbsv01p0051g05){#F5}

![**Relationship between GoLoco motif sequences from all GoLoco proteins identified to date.** Unrooted dendrogram was generated by Clustal-W [@B33] and TreeView [@B34] using GoLoco motif sequences originally published in our comprehensive review of the GoLoco motif [@B91]. The individual GoLoco motifs from tandem arrays (Fig. [5](#F5){ref-type="fig"}A) are numbered GL1 to GL4 starting from the first N-terminal motif. Species abbreviations: a, *Anopheles gambiae* (mosquito); Cb, *Caenorhabditis briggsae*; Ce, *Caenorhabditis elegans*; d, *Drosophila*; f, *Fugu rubripes*; h, human; m, mouse; r, rat; z, *Danio rerio* (zebrafish). Note that there are two LGN-like proteins encoded by the genome of *Fugu rubripes*; we have denoted the one more closely-related to mammalian LGN/GPSM2 as fGPSM2 (Ensembl translation ID SINFRUP00000160450) and the more distantly-related protein as fLGN2 (Ensembl SINFRUP00000146023). Two conclusions can immediately be drawn from this analysis: (i) *Drosophila* Pins, which has only three GoLoco motifs (Fig. [8](#F8){ref-type="fig"}) *vs* the four motifs of GPSM1 and GPSM2 proteins, has lost the second motif, since dPins GL2 is most similar to GL3 of GPSM1/2 proteins, and dPins GL3 is most similar to GL4 of GPSM1/2 proteins; (ii) the triple GoLoco motif protein GPSM3 (*a.k.a.* G18) is not directly related to the tandem GoLoco arrays of GPSM1/2 proteins (*i.e.*, GPSM3 is not merely missing the N-terminal TPR region of GPSM1/2).](ijbsv01p0051g06){#F6}

![**Experimental paradigm used to demonstrate that GoLoco motif-derived peptides can uncouple heterotrimeric G-protein signaling, but have no intrinsic ability to directly activate Gβγ-dependent signaling.** (A) The dopamine agonist quinpirole, when applied to AtT-20 cells stably or transiently expressing the D2-dopamine receptor [@B116], activates Gi-heterotrimers and elicits potassium current via the Kir3.1/3.2 channel (as activated by free Gβγ). Upon GTP hydrolysis by Gα, the heterotrimer of Gα·GDP and Gβγ subunits can reform, restoring the "coupled" receptor/G-protein complex. However, in the presence of GoLoco motif-derived peptides, Gα can become trapped in a Gα·GDP/GoLoco complex, preventing Gβγ reassociation and re-coupling to the 7TM receptor. (B) Sample electrophysiological data in support of the model presented in part (A). AtT-20 cells under whole-cell patch-clamp configuration to measure potassium currents were treated with repeated quinpirole pulses (orange circles) or buffer (open circles) after loading with 10 μM RGS12 GoLoco peptide (left panel) or control scrambled peptide (right panel).](ijbsv01p0051g07){#F7}

![Known interactions between apical polarity proteins PAR3, PAR6, atypical PKC (aPKC), and *Drosophila* Inscuteable (dInsc), Partner of Inscuteable (Pins), and Gαi in *Drosophila* neuroblast asymmetric cell division. ARM, homology to Armadillo repeats. Red circles, TPR motifs; yellow rectangles, GoLoco motifs.](ijbsv01p0051g08){#F8}

![**Alignment of *C. elegans* GPR-1 and GPR-2 protein sequences**. Although individual tetratricopeptide repeats (TPRs) are not easily identified within the N-termini of GPR-1 and GPR-2 (as they are within mammalian and *Drosophila* homologs; Figs. [5](#F5){ref-type="fig"}A & [8](#F8){ref-type="fig"}), amino-acids 14 to 341 (boxed in grey) are predicted by protein-fold recognition algorithms (*e.g.*, ref. [@B36]) to fold into a right-handed alpha-alpha superhelix (SCOP identifier d1ld8a\_; expect value 5 x 10^-5^) similar to folds exhibited by TPR-containing proteins [@B130]. Also boxed is the conserved GoLoco motif signature (amino-acids 425-442) and its consensus as defined in [@B91]. Consensus symbols for amino-acid character are hyphen (-), acidic; Φ, hydrophobic; Ψ, large aliphatic; (+), basic; and π, small side chain.](ijbsv01p0051g09){#F9}

![**A**. Summary of data implicating Gα and its regulators in generation of asymmetric anterior/posterior forces acting on the mitotic spindle of one-cell *C. elegans* zygotes during ACD (reviewed in [@B91]). **B**. Model of a novel Gα nucleotide cycle incorporating the data of part A. RGS-7 contains N-terminal homology to conserved region 2 ("C2") of protein kinase C and an RGS-box presumed in the model to exert GAP activity. Force arrow denotes speculation that, at least in the nematode, the GTP-bound form of GOA-1/GPA-16 interacts, directly or indirectly, with astral MTs to generate force on the mitotic spindle.](ijbsv01p0051g10){#F10}

![**Predicted effects of RIC-8 and RGS-7 on the Gα nucleotide cycle underlying MT force generation in ACD. A.**Steady-state GTP hydrolysis of Gα subunits is known to be limited by nucleotide exchange (*k~ex~*), not by the intrinsic GTPase rate (*k~cat~*) [@B141], [@B142]. **B.** RGS‑7 GAP activity, while by definition accelerating the intrinsic GTPase rate of Gα (*k~cat\'~* \> *k~cat~*), will have *no effect on steady-state* GTP hydrolysis, as the limiting rate for isolated Gα subunits remains GDP release, a key component of *k~ex~* [@B141], [@B142]. **C.** RIC-8 GEF activity should accelerate nucleotide exchange (*k~ex\'~* \> *k~ex~*) and increase observed rate of steady-state GTP hydrolysis (up to the new limiting rate of *k~cat~*if *k~ex\'~* \> *k~cat~*). **D.** Addition of both RIC-8 GEF and RGS-7 GAP activities should dramatically accelerate steady-state GTP hydrolysis *vs* the basal condition in (**A**), up to whichever component rate is limiting (*k~ex\'~*or*k~cat\'~*). **E.** A graphical representation of predicted steady state GTP hydrolysis by Gα in the presence of these two novel G-protein cycle components. The ordinate represents the amount of inorganic phosphate (Pi) released, and the abscissa represents time.](ijbsv01p0051g11){#F11}
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